APA (7th ed.) Citation

EA, L., LJ, A., DB, R., JS, W., E, E., Q, G., . . . EY, C. (2022). Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries. JAMA ophthalmology, 140(4), 345. https://doi.org/10.1001/jamaophthalmol.2022.0052

Chicago Style (17th ed.) Citation

EA, Lundeen, Andes LJ, Rein DB, Wittenborn JS, Erdem E, Gu Q, Saaddine J, Imperatore G, and Chew EY. "Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries." JAMA Ophthalmology 140, no. 4 (2022): 345. https://doi.org/10.1001/jamaophthalmol.2022.0052.

MLA (9th ed.) Citation

EA, Lundeen, et al. "Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries." JAMA Ophthalmology, vol. 140, no. 4, 2022, p. 345, https://doi.org/10.1001/jamaophthalmol.2022.0052.